Logo image
Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter
Journal article   Open access   Peer reviewed

Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter

Shaili Aggarwal, Xiaonan Liu, Caitlyn Rice, Paul Menell, Philip J. Clark, Nicholas Paparoidamis, You-cai Xiao, Joseph M. Salvino, Andréia C. K. Fontana, Rodrigo A. España, …
ACS chemical neuroscience, v 10(8), pp 3718-3730
24 Jun 2019
PMID: 31184115
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703927View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Allosteric modulation cocaine use disorder dopamine transporter hybrid structure based method substituted cysteine scanning accessibility method
The dopamine transporter (DAT) serves a pivotal role in controlling dopamine (DA)-mediated neurotransmission by clearing DA from synaptic and perisynaptic spaces and controlling its action at postsynaptic DA receptors. Major drugs of abuse such as amphetamine and cocaine interact with DAT to mediate their effects by enhancing extracellular DA concentrations. We previously identified a novel allosteric site in the related human serotonin transporter that lies outside the central substrate and inhibitor binding pocket. We used the hybrid structure based (HSB) method to screen for allosteric modulator molecules that target a similar site in DAT. We identified a compound, KM822, that was found to be a selective, noncompetitive inhibitor of DAT. We confirmed the structural determinants of KM822 allosteric binding within the allosteric site by structure/function and substituted cysteine scanning accessibility biotinylation experiments. In the in vitro cell-based assay and ex vivo in both rat striatal synaptosomal and slice preparations, KM822 was found to decrease the affinity of cocaine for DAT. The in vivo effects of KM822 on cocaine were tested on psychostimulant-associated behaviors in a planarian model where KM822 specifically inhibited the locomotion elicited by DAT-interacting stimulants amphetamine and cocaine. Overall, KM822 provides a unique opportunity as a molecular probe to examine allosteric modulation of DAT function.

Metrics

18 Record Views
26 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemistry & Molecular Biology
Chemistry, Medicinal
Neurosciences
Logo image